Miriam Y. Kim, MD

Miriam Y. Kim, MD

Assistant Professor

Address:
Division of Oncology
Mail Stop 8007-0057-06
Washington University
660 South Euclid Avenue
St. Louis, MO 63110

11th Floor Mid Campus Center (office)

Admin:
Gina Gentilini
ggentilini@wustl.edu

Research Interests
  • CAR T cells
  • Immunotherapy
  • AML
Research

My goal is to a develop chimeric antigen receptor T cells as a safe and effective therapy for AML. To this end, I am exploring different target antigens for CAR T cell therapy, investigating mechanisms to enhance the anti-tumor effect of CAR T cells, and finding methods to circumvent the toxicity associated with T cell immunotherapy in the setting of myeloid malignancies.

Biosketch

Education

  • 2008: MD, Seoul National University, Seoul, Korea
  • 2004: BS in Biotechnology, Yonsei University, Seoul, Korea

Post-Graduate Training

  • 2017-2014: Postdoctoral Researcher, University of Pennsylvania, Philadelphia, PA
  • 2014-2011: Fellow, Hematology and Oncology, University of Southern California, Los Angeles, CA
  • 2011-2008: Resident, Internal Medicine, SUNY Downstate Medical Center, Brooklyn, NY

Academic Positions

  • present-2020: Assistant Professor, Department of Medicine, Washington University School of Medicine, St. Louis, MO
  • 2020-2017: Instructor, Department of Medicine, Washington University School of Medicine, St. Louis, MO

Board Certification

  • 2014: American Board of Internal Medicine, Hematology
  • 2014: American Board of Internal Medicine, Medical Oncology

Honors & Awards

  • 2020: ASH-EHA Translational Research Training in Hematology
  • 2020: Washington University Division of Physician-Scientists Dean’s Scholars Program
  • 2019: Alex’s Lemonade Stand Foundation Young Investigator Grant
  • 2017: Marlene Shlomchik Fellowship in Cancer Research
  • 2016: ASH Abstract Achievement Award
  • 2016: ASGCT Meritorious Abstract Travel Award
  • 2012: ASH Abstract Achievement Award

Professional Societies & Organizations

  • present-2020: American Society for Transplantation and Cellular Therapy
  • present-2020: Society for Immunotherapy of Cancer
  • present-2015: American Society of Gene & Cell Therapy
  • present-2011: American Society of Hematology